Open Access

COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)

  • Authors:
    • Shuoqi Zhang
    • Jinming Zhang
    • Chunxu Wang
    • Xiaojing Chen
    • Xinyi Zhao
    • Haijiao Jing
    • Huan Liu
    • Zhuxin Li
    • Lihua Wang
    • Jialan Shi
  • View Affiliations

  • Published online on: January 13, 2021     https://doi.org/10.3892/ijmm.2021.4854
  • Article Number: 21
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

During the coronavirus disease 2019 (COVID‑19) pandemic, some patients with severe COVID‑19 exhibited complications such as acute ischemic stroke (AIS), which was closely associated with a poor prognosis. These patients often had an abnormal coagulation, namely, elevated levels of D‑dimer and fibrinogen, and a low platelet count. Certain studies have suggested that COVID‑19 induces AIS by promoting hypercoagulability. Nevertheless, the exact mechanisms through which COVID‑19 leads to a hypercoagulable state in infected patients remain unclear. Understanding the underlying mechanisms of hypercoagulability is of utmost importance for the effective treatment of these patients. The present review aims to summarize the current status of research on COVID‑19, hypercoagulability and ischemic stroke. The present review also aimed to shed light into the underlying mechanisms through which COVID‑19 induces hypercoagulability, and to provide therapies for different mechanisms for the more effective treatment of patients with COVID‑19 with ischemic stroke and prevent AIS during the COVID‑19 pandemic.

Related Articles

Journal Cover

March-2021
Volume 47 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang S, Zhang J, Wang C, Chen X, Zhao X, Jing H, Liu H, Li Z, Wang L, Shi J, Shi J, et al: COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review). Int J Mol Med 47: 21, 2021
APA
Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H. ... Shi, J. (2021). COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review). International Journal of Molecular Medicine, 47, 21. https://doi.org/10.3892/ijmm.2021.4854
MLA
Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H., Liu, H., Li, Z., Wang, L., Shi, J."COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)". International Journal of Molecular Medicine 47.3 (2021): 21.
Chicago
Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H., Liu, H., Li, Z., Wang, L., Shi, J."COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review)". International Journal of Molecular Medicine 47, no. 3 (2021): 21. https://doi.org/10.3892/ijmm.2021.4854